Skip to search.
 FTSE 100 Down 0.29%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC Ticker: 925288/ISIN: GB0009252882
21.50 Down 0.23(1.06%) 30 Sep 19:06
Prev Close:21.73
Open:21.04
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.18705
Next Earnings Date:N/A
Day's Range:21.00 - 21.50
52wk Range:19.08 - 22.98
Volume:2,157
Avg Vol (3m):2,430
Market Cap:103.50b
P/E (ttm):2,687.50
EPS (ttm):0.01
Div & Yield:0.99 (4.69%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.21
P/S (ttm):3.21
Ex-Dividend Date:11-Aug-16

Analysts

Annual EPS Est (Dec-16) :97.56
Quarterly EPS Est (Sep-16) :29.96
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback